Kuang-Kai Liu Selected Research

7- chloro- 6- piperidin- 1- ylquinoline- 5,8- dione

4/2011

7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel ROCK inhibitor blocks cytoskeleton function and cell migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kuang-Kai Liu Research Topics

Disease

7	Neoplasms (Cancer) 11/2021 - 05/2008
2	Lung Neoplasms (Lung Cancer) 11/2021 - 08/2010
2	Carcinoma (Carcinomatosis) 04/2011 - 08/2010
1	Pleural Effusion (Pleural Effusions) 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Embryonal Carcinoma 05/2014
1	Carcinogenesis 08/2010

Drug/Important Bio-Agent (IBA)

6	NanodiamondsIBA 01/2019 - 09/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 08/2010
3	CarbonIBA 01/2017 - 08/2010
2	ErbB Receptors (EGF Receptor)IBA 11/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 08/2010
2	Cetuximab (Erbitux)FDA Link 01/2019 - 01/2017
1	Gefitinib (Iressa)FDA Link 11/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	SurvivinIBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	EGFR inhibitor SP101IBA 11/2021
1	Caspase 3 (Caspase-3)IBA 11/2021
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	7- chloro- 6- piperidin- 1- ylquinoline- 5,8- dioneIBA 04/2011

Therapy/Procedure

3	Therapeutics 11/2021 - 08/2010
1	Lasers (Laser) 05/2008